A genome-wide association study of bronchodilator response in participants of European and African ancestry from six independent cohorts
Open Access
- 1 April 2022
- journal article
- research article
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 8 (2)
Abstract
Introduction: Bronchodilator response (BDR) is a measurement of acute bronchodilation in response to short-acting β2-agonists, with a heritability between 10 and 40%. Identifying genetic variants associated with BDR may lead to a better understanding of its complex pathophysiology.Methods: We performed a genome-wide association study (GWAS) of BDR in six adult cohorts with participants of European ancestry (EA) and African ancestry (AA) including community cohorts and cohorts ascertained on the basis of obstructive pulmonary disease. Validation analysis was carried out in two paediatric asthma cohorts.Results: A total of 10 623 EA and 3597 AA participants were included in the analyses. No single nucleotide polymorphism (SNP) was associated with BDR at the conventional genome-wide significance threshold (p−8). Performing fine mapping and using a threshold of p−6to identify suggestive variants of interest, we identified three SNPs with possible biological relevance: rs35870000 (withinFREM1), which may be involved in IgE- and IL5-induced changes in airway smooth muscle cell responsiveness; rs10426116 (withinZNF284), a zinc finger protein, which has been implicated in asthma and BDR previously; and rs4782614 (nearATP2C2), involved in calcium transmembrane transport. Validation in paediatric cohorts yielded no significant SNPs, possibly due to age–genotype interaction effects.Conclusion: Ancestry-stratified and ancestry-combined GWAS meta-analyses of over 14 000 participants did not identify genetic variants associated with BDR at the genome-wide significance threshold, although a less stringent threshold identified three variants showing suggestive evidence of association. A common definition and protocol for measuring BDR in research may improve future efforts to identify variants associated with BDR.Keywords
Funding Information
- AstraZeneca
- Takeda Pharmaceutical Company
- Chiesi Farmaceutici
- National Institutes of Health (5T32HL007035, R01 HL089856, R01 HL142992, R01HL130512, R01HL137927, R01HL147148, R01HL149861, RO1 HL127332, U01 HL137880, U01 HL65899)
- Roche
- Novartis Pharmaceuticals Corporation
- COPD Foundation
- Pfizer
- Grifols
- Bayer HealthCare
- Sunovion
- Nycomed GmbH
- Forest Research Institute
- Boehringer Ingelheim
- GlaxoSmithKline
- Ikaria
- National Heart, Lung, and Blood Institute (75N92019D00031, HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, HHSN268201500001I, N01-HC-25195)
- Bellerophon Therapeutics
- Sanofi
- Genentech
- Regeneron Pharmaceuticals
This publication has 43 references indexed in Scilit:
- A genome-wide association study of bronchodilator response in Latinos implicates rare variantsJournal of Allergy and Clinical Immunology, 2014
- Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS): Table 1Thorax, 2013
- An integrated map of genetic variation from 1,092 human genomesNature, 2012
- Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response GenePLOS Genetics, 2012
- METAL: fast and efficient meta-analysis of genomewide association scansBioinformatics, 2010
- Genetic Epidemiology of COPD (COPDGene) Study DesignCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2010
- Beta-2 adrenergic receptor genetic polymorphisms and asthmaJournal of Clinical Pharmacy and Therapeutics, 2009
- ARG1 Is a Novel Bronchodilator Response GeneAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthmaPharmacogenetics and Genomics, 2008
- Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)European Respiratory Journal, 2008